BA
TNDM icon

BlackRock Advisors’s Tandem Diabetes Care TNDM Stock Holding History

BlackRock Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$22K Sell
1,040
-36,700
-97% -$1.41M ﹤0.01% 3439
2016
Q3 		$2.89M Sell
37,740
-24,703
-40% -$1.8M ﹤0.01% 1333
2016
Q2 		$4.71M Sell
62,443
-5,248
-8% -$422K ﹤0.01% 1131
2016
Q1 		$5.9M Buy
67,691
+2,441
+4% +$214K 0.01% 1034
2015
Q4 		$7.71M Buy
65,250
+3,833
+6% +$380K 0.01% 955
2015
Q3 		$5.41M Buy
61,417
+540
+0.9% +$62.9K 0.01% 1061
2015
Q2 		$6.6M Buy
60,877
+10,379
+21% +$1.29M 0.01% 904
2015
Q1 		$6.37M Buy
50,498
+8,759
+21% +$1.14M 0.01% 916
2014
Q4 		$5.3M Buy
41,739
+41,391
+11,894% +$5.74M 0.01% 957
2014
Q3 		$47K Hold
348
– – ﹤0.01% 3282
2014
Q2 		$57K Sell
348
-137
-28% -$23.3K ﹤0.01% 3233
2014
Q1 		$107K Buy
485
+39
+9% +$9.95K ﹤0.01% 3003
2013
Q4 		$115K Buy
+446
New +$102K ﹤0.01% 2982

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's TNDM Position: Q4 2016 in Review

BlackRock Advisors reduced its Tandem Diabetes Care (TNDM) stake by 97% in Q4 2016, selling an estimated $1.41M and leaving 1,040 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

BlackRock Advisors first reported a position in TNDM in Q4 2013 and has held it in 13 quarters since. The position peaked at $7.71M in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

  • BlackRock Advisors held 1,040 shares of Tandem Diabetes Care worth $22K as of Q4 2016.
  • BlackRock Advisors sold 36,700 Tandem Diabetes Care shares in Q4 2016, an estimated $1.41M.
  • Tandem Diabetes Care made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3439 holding.
  • BlackRock Advisors first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Advisors's Tandem Diabetes Care position peaked at $7.71M in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.